SCHEMBL4704205

SCHEMBL4704205

OCC1OCc2cc(Cl)ccc21

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TRPM5 Q9NZQ8 10/20 0.41
TRPM4 Q8TD43 6/20 0.41
ADRA2A P08913 1/20 0.40
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40
ADRA1D P25100 1/20 0.40
ADRA1A P35348 1/20 0.40
ADRA1B P35368 1/20 0.40
MAP3K14 Q99558 1/20 0.36
HTR2C P28335 4/20 0.35
HTR2A P28223 3/20 0.35
HTR2B P41595 3/20 0.35
PRMT5 O14744 3/20 0.33
WDR77 Q9BQA1 3/20 0.33
MGAM O43451 1/20 0.33
GAA P10253 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5088665 0.87 ADRA2A (0.38) TRPM5TRPM4ADRA2AADRA2BADRA2C
SCHEMBL4702666 0.83 ADRA2A (0.37) TRPM5TRPM4ADRA2AADRA2BADRA2C
SCHEMBL5092292 0.81 FFAR1 (0.43) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL17361494 0.79 PNMT (0.41) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL17193850 0.79 TRPM5 (0.41) TRPM5ADRA2AADRA2BADRA2CADRA1D
SCHEMBL9682302 0.79 ADRA2A (0.40) TRPM5TRPM4ADRA2AADRA2BADRA2C
SCHEMBL18427870 0.79 TRPM5 (0.41) TRPM5ADRA2AADRA2BADRA2CADRA1D
SCHEMBL17193852 0.79 ADRA2A (0.40) TRPM5TRPM4ADRA2AADRA2BADRA2C
SCHEMBL4706203 0.78 ADRA2A (0.33) TRPM5TRPM4ADRA2AADRA2BADRA2C
SCHEMBL5097822 0.77 MAP3K14 (0.42) TRPM5TRPM4ADRA2AADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567489-B1 PYRROLIDIN-2-ONE DERIVATIVES AS INHIBITORS OF THROMBIN AND FACTOR XA GLAXO GROUP LTD (GB) 2008-07-23 EP disclosed
US-20060166985-A1 Pyrrolydin-2-one derivatives as inhibitors of thrombin and factor xa GLAXO GROUP LIMITED (GB) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166985-A1 Pyrrolydin-2-one derivatives as inhibitors of thrombin and factor xa TFPI, TFPI2, SERPINC1 TRPM5 3212/4885TRPM4 3972/4885ADRA2A 3888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.